Educational support for the freeze drying community
![](/46/pdcnewsitem/03/81/35/spscientificpr70-imageA.jpg)
SP Scientific has announced their next series of educational events to be held during 2016 for scientists involved with lyophilization.
Information and registration details for these upcoming events, which include LyoLearn webinars, seminars and hands-on training courses, is available through the SP LyoTech Center. In addition to upcoming events, the LyoTech Center offers a comprehensive repository of previously recorded webinars; informative articles and technical papers; and a variety of free tools and programs to assist freeze dryer users.
LyoLearn webinars are free online seminars based on topics of interest to lyophilization scientists and presented by industry experts. The monthly live sessions allow participants to interact with renowned freeze-drying specialists, such as Dr John Carpenter, Dr Steve Nail, Dr Michael Pikal and other leading experts from the freeze-drying community. Up-and-coming Lyolearn webinar topics include 'Heterogeneity in Frozen and Desiccated Formulations' presented by Dr Alptekin Aksan from the University of Minnesota, 'Experimental Aspects of Measuring the Vial Heat Transfer Coefficient in Pharmaceutical Freeze Drying' presented by Dr Lindsay Wegiel at Baxter Pharmaceutical Solutions, LLC, and ‘Dynamic Vapor Sorption: Quantifying the Amorphous Phase in a Partially Crystalline Freeze Dried Product' presented by Claudia Kunz from the University of Erlangen-Nürnberg.
Another important component of SP’s educational program is in-person training events. Lyophilization equipment is a significant investment, and in an effort to help organizations maximize the return on their investment, SP Scientific has developed a program of courses to assure personnel are fully trained in instrument operation and maintenance.
In May 2016 the popular 4-day hands-on training course ‘Lyophilization Cycle Development & Optimization’, presented by Dr Jeff Schwegman, will focus on following the freeze drying process from formulation and thermal analysis to cycle development and optimization, packaging and troubleshooting. Attendees will have the chance to optimize their learning experience by using tangible applications in a controlled setting.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance